Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Worldwide Oncology Biosimilars Market Research Report 2021 by Type, Application, Participants and Countries, COVID-19 Impact, Forecast Year to 2026

  • PRO4486878
  • 129 Pages
  • May 2021
  • Pharmaceuticals
Download Sample    Get Discount   
 
Due to the high popularity of this product/service in North America and Asia, the growth trend of Oncology Biosimilars in recent years and the growth of consumers' demand is expected to drive the global Oncology Biosimilars market.

Geographically, the global Oncology Biosimilars market is divided into North America, Europe, Latin America, Asia Pacific, Middle East & Africa.

North America, Asia and Europe have significant position in the this market, big players operating in there. The U.S. is accounting for a major share of the total Oncology Biosimilars market in North America.

Significant participants active in the global Oncology Biosimilars market include: Dr. Reddy's Laboratories Ltd., Amgen Biosimilars, Samsung Bioepis Co. Ltd., Intas Pharmaceuticals Ltd., Pfizer, Inc., Celltrion Inc., Sandoz International GmbH, Teva Pharmaceutical Industries Ltd...

Global Oncology Biosimilars Market Segmentation:

Oncology Biosimilars market, by Oncology Biosimilars type:

G-CSF

Hematopoietic Agents

Monoclonal Antibodies

…

Oncology Biosimilars market, by Application:

Retail pharmacies

Hospital pharmacies

Online pharmacies

…

Oncology Biosimilars Market Research Report 2014-2026, by region:

North America

The U.S.

Canada

Europe

Germany

UK

France

Italy

Spain

Rest of Europe

Latin America

Mexico

Brazil

Argentina

Pan Asia Pacific

China

Japan

South Korea

South East Asia Region

India

Australia

Middle East and Africa

Saudi Arabia

UAE

Qatar

Egypt

Nigeria

South Africa

Rest of MEA

The database is running updated by a group of research experts to always reflect the latest trends and information.

Table of Content

1. Introduction

1.1 Definition of the Market

1.2 Research Purpose

1.3 Scope of the Study

1.4 Stakeholders

1.5 Geography Coverage

1.6 Currency Under Consideration

1.7 Volume Units

1.8 Review Cycle

1.9 Summary and Key Findings of the Research

2 Research Methodology

2.1 Research Data

2.1.1 Secondary Data

2.1.2 Primary Data

2.2 Market Size Estimation

2.2.1 Bottom-Up Approach

2.2.2 Top-Down Approach (Involves time, Space, and Persons)

2.3 Data Triangulation

2.4 Assumptions

2.5 Hypothesis of this Research, Clear, Specific, and Testable Statement of This Research

2.6 Limitations of Our Study

2.7 Scene Based Modeling

2.8 Covid-19 Impact/Evaluation

3. Market Dynamics

3.1 Driving Factors

3.1.1 Rising Demand in one or More of the Following Regions: North America, Europe, Asia-Pacific, Latin America, Middle East & Africa

3.1.2 Increasing Use of Oncology Biosimilars by Different End-User/Applications

3.2 Restraints and Challenges in the Market

3.3 Opportunities

4. Global Oncology Biosimilars Market-Segmentation

4.1 By Type

4.1.1 G-CSF

4.1.2 Hematopoietic Agents

4.1.3 Monoclonal Antibodies

4.2 By End-User/Application Industry

4.2.1 Retail pharmacies

4.2.2 Hospital pharmacies

4.2.3 Online pharmacies

4.3 By Geography

4.3.1 North America Oncology Biosimilars Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)

4.3.1.1 North America Oncology Biosimilars Production from 2014-2020

4.3.1.2 North America Oncology Biosimilars Consumption from 2014-2020

4.3.1.3 North America Oncology Biosimilars Import and Export from 2014-2020

4.3.1.4 North America Oncology Biosimilars Market Value ($) and Growth (%) by Type from 2019-2020

4.3.1.5 North America Oncology Biosimilars Market Value ($) and Growth (%) by Application from 2019-2020

4.3.1.6 North America Oncology Biosimilars Market Value ($) and Growth (%) by Countries from 2019-2020

4.3.1.7 Top North America Oncology Biosimilars Participants Value ($) and Market Share (%) in 2019

4.3.2 Europe Oncology Biosimilars Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)

4.3.2.1 Europe Oncology Biosimilars Production from 2014-2020

4.3.2.2 Europe Oncology Biosimilars Consumption from 2014-2020

4.3.2.3 Europe Oncology Biosimilars Import and Export from 2014-2020

4.3.2.4 Europe Oncology Biosimilars Market Value ($) and Growth (%) by Type from 2019-2020

4.3.2.5 Europe Oncology Biosimilars Value ($) and Growth (%) by Application from 2019-2020

4.3.2.6 Europe Oncology Biosimilars Market Value ($) and Growth (%) by Countries from 2019-2020

4.3.2.7 Top Europe Oncology Biosimilars Participants Value ($) and Market Share (%) in 2019

4.3.3 Asia-Pacific Oncology Biosimilars Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)

4.3.3.1 Asia-Pacific Oncology Biosimilars Production from 2014-2020

4.3.3.2 Asia-Pacific Oncology Biosimilars Consumption from 2014-2020

4.3.3.3 Asia-Pacific Oncology Biosimilars Import and Export from 2014-2020

4.3.3.4 Asia-Pacific Oncology Biosimilars Value ($) and Growth (%) by Type from 2019-2020

4.3.3.5 Asia-Pacific Oncology Biosimilars Value ($) and Growth (%) by Application from 2019-2020

4.3.3.6 Asia-Pacific Oncology Biosimilars Value ($) and Growth (%) by Countries from 2019-2020

4.3.3.7 Top Asia-Pacific Oncology Biosimilars Participants Value ($) and Market Share (%) in 2019

4.3.4 Latin America Oncology Biosimilars Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)

4.3.4.1 Latin America Oncology Biosimilars Production from 2014-2020

4.3.4.2 Latin America Oncology Biosimilars Consumption from 2014-2020

4.3.4.3 Latin America Oncology Biosimilars Import and Export from 2014-2020

4.3.4.4 Latin America Oncology Biosimilars Value ($) and Growth (%) by Type from 2019-2020

4.3.4.5 Latin America Oncology Biosimilars Value ($) and Growth (%) by Application from 2019-2020

4.3.4.6 Latin America Oncology Biosimilars Value ($) and Growth (%) by Countries from 2019-2020

4.3.4.7 Top Latin America Oncology Biosimilars Participants Value ($) and Market Share (%) in 2019

4.3.5 Middle East & Africa Oncology Biosimilars Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)

4.3.5.1 Middle East & Africa Oncology Biosimilars Production from 2014-2020

4.3.5.2 Middle East & Africa Oncology Biosimilars Consumption from 2014-2020

4.3.5.3 Middle East & Africa Oncology Biosimilars Import and Export from 2014-2020

4.3.5.4 Middle East & Africa Oncology Biosimilars Value ($) and Growth (%) by Type from 2019-2020

4.3.5.5 Middle East & Africa Oncology Biosimilars Value ($) and Growth (%) by Application from 2019-2020

4.3.5.6 Middle East & Africa Oncology Biosimilars Value ($) and Growth (%) by Countries from 2019-2020

4.3.5.7 Top Middle East & Africa Oncology Biosimilars Participants Value ($) and Market Share (%) in 2019

5. Competitive Intelligence – Company Profiles

5.1 Dr. Reddy's Laboratories Ltd.

5.1.1 Dr. Reddy's Laboratories Ltd. Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.1.2 Dr. Reddy's Laboratories Ltd. Sales, Growth Rate and Global Market Share from 2014-2020

5.2 Amgen Biosimilars

5.2.1 Amgen Biosimilars Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.2.2 Amgen Biosimilars Sales, Growth Rate and Global Market Share from 2014-2020

5.3 Samsung Bioepis Co. Ltd.

5.3.1 Samsung Bioepis Co. Ltd. Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.3.2 Samsung Bioepis Co. Ltd. Sales, Growth Rate and Global Market Share from 2014-2020

5.4 Intas Pharmaceuticals Ltd.

5.4.1 Intas Pharmaceuticals Ltd. Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.4.2 Intas Pharmaceuticals Ltd. Sales, Growth Rate and Global Market Share from 2014-2020

5.5 Pfizer, Inc.

5.5.1 Pfizer, Inc. Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.5.2 Pfizer, Inc. Sales, Growth Rate and Global Market Share from 2014-2020

5.6 Celltrion Inc.

5.6.1 Celltrion Inc. Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.6.2 Celltrion Inc. Sales, Growth Rate and Global Market Share from 2014-2020

5.7 Sandoz International GmbH

5.7.1 Sandoz International GmbH Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.7.2 Sandoz International GmbH Sales, Growth Rate and Global Market Share from 2014-2020

5.8 Teva Pharmaceutical Industries Ltd

5.8.1 Teva Pharmaceutical Industries Ltd Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.8.2 Teva Pharmaceutical Industries Ltd Sales, Growth Rate and Global Market Share from 2014-2020

6. Investment Analysis

6.1 Fundamental Analysis (Porter's Five Forces Analysis)

6.2 Technical Preparation Analysis

6.3 Risk Evaluating Analysis

6.4 Estimated Investment Pay-Back Period

7. Future Forecast of the Global Oncology Biosimilars Market from 2021-2026

7.1 Future Forecast of Global Oncology Biosimilars Market from 2021-2026 Segment by Region

7.2 Future Forecast of the Global Oncology Biosimilars Market from 2021-2026 Segment by Types

7.3 Future Forecast of the Global Oncology Biosimilars Market from 2021-2026 Segment by End-User/Applications

8 Appendix

8.1 Discussion Guide

8.2 Related Reports

8.3 Author List

9 Disclaimer

List of Tables and Figures

Global Oncology Biosimilars Market Value ($) and Growth Rate of Oncology Biosimilars from 2014-2026

Global Oncology Biosimilars Production and Growth Rate Segment by Product Types from 2014-2026F

Global Oncology Biosimilars Consumption and Growth Rate Segment by End-User/Application from 2014-2026E

Table Driving Factors for this Market (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa)

Table Global Oncology Biosimilars Production and Growth Rate Segment by Product Types from 2014-2020

Table Global Oncology Biosimilars Value ($) and Growth Rate Segment by Product Types from 2014-2020

Figure G-CSF of Oncology Biosimilars

Figure Hematopoietic Agents of Oncology Biosimilars

Figure Monoclonal Antibodies of Oncology Biosimilars

Table Global Oncology Biosimilars Consumption and Growth Rate Segment by End-User/Application from 2014-2020

Table Global Oncology Biosimilars Value ($) and Growth Rate Segment by End-User/Application from 2014-2020

Figure Retail pharmacies of Oncology Biosimilars

Figure Hospital pharmacies of Oncology Biosimilars

Figure Online pharmacies of Oncology Biosimilars

Table Global Oncology Biosimilars Production Value ($) by Regions

Table Global Oncology Biosimilars Production Value Share by Regions

Table Global Oncology Biosimilars Production by Regions

Table Global Oncology Biosimilars Production Share by Regions

Table Global Oncology Biosimilars Consumption by Regions

Table Global Oncology Biosimilars Consumption Share by Regions

Figure North America Oncology Biosimilars Production and Growth Rate from 2014-2020

Figure North America Oncology Biosimilars Consumption and Growth Rate from 2014-2020

Table North America Oncology Biosimilars Import and Export from 2014-2020

Table North America Oncology Biosimilars Value ($) and Growth (%) by Type from 2019-2020

Table North America Oncology Biosimilars Value ($) and Growth (%) by Application from 2019-2020

Table North America Oncology Biosimilars Value ($) and Growth (%) by Countries from 2019-2020

Table Top North America Oncology Biosimilars Participants Value ($) and Market Share (%) in 2019

Figure Europe Oncology Biosimilars Production and Growth Rate from 2014-2020

Figure Europe Oncology Biosimilars Consumption and Growth Rate from 2014-2020

Table Europe Oncology Biosimilars Import and Export from 2014-2020

Table Europe Oncology Biosimilars Value ($) and Growth (%) by Type from 2019-2020

Table Europe Oncology Biosimilars Value ($) and Growth (%) by Application from 2019-2020

Table Europe Oncology Biosimilars Market Value ($) and Growth (%) by Countries from 2019-2020

Table Top Europe Oncology Biosimilars Participants Value ($) and Market Share (%) in 2019

Figure Asia-Pacific Oncology Biosimilars Production and Growth Rate from 2014-2020

Figure Asia-Pacific Oncology Biosimilars Consumption and Growth Rate from 2014-2020

Table Asia-Pacific Oncology Biosimilars Import and Export from 2014-2020

Table Asia-Pacific Oncology Biosimilars Value ($) and Growth (%) by Type from 2019-2020

Table Asia-Pacific Oncology Biosimilars Value ($) and Growth (%) by Application from 2019-2020

Table Asia-Pacific Oncology Biosimilars Value ($) and Growth (%) by Countries from 2019-2020

Table Top Asia-Pacific Oncology Biosimilars Participants Value ($) and Market Share (%) in 2019

Figure Latin America Oncology Biosimilars Production and Growth Rate from 2014-2020

Figure Latin America Oncology Biosimilars Consumption and Growth Rate from 2014-2020

Table Latin America Oncology Biosimilars Import and Export from 2014-2020

Table Latin America Oncology Biosimilars Value ($) and Growth (%) by Type from 2019-2020

Table Latin America Oncology Biosimilars Value ($) and Growth (%) by Application from 2019-2020

Table Latin America Oncology Biosimilars Value ($) and Growth (%) by Countries from 2019-2020

Table Top Latin America Oncology Biosimilars Participants Value ($) and Market Share (%) in 2019

Figure Middle East & Africa Oncology Biosimilars Production and Growth Rate from 2014-2020

Figure Middle East & Africa Oncology Biosimilars Consumption and Growth Rate from 2014-2020

Table Middle East & Africa Oncology Biosimilars Import and Export from 2014-2020

Table Middle East & Africa Oncology Biosimilars Value ($) and Growth (%) by Type from 2019-2020

Table Middle East & Africa Oncology Biosimilars Value ($) and Growth (%) by Application from 2019-2020

Table Middle East & Africa Oncology Biosimilars Value ($) and Growth (%) by Countries from 2019-2020

Table Top Middle East & Africa Oncology Biosimilars Participants Value ($) and Market Share (%) in 2019

Table Dr. Reddy's Laboratories Ltd. Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Dr. Reddy's Laboratories Ltd. Sales and Growth Rate from 2014-2020

Figure Dr. Reddy's Laboratories Ltd. Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Amgen Biosimilars Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Amgen Biosimilars Sales and Growth Rate from 2014-2020

Figure Amgen Biosimilars Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Samsung Bioepis Co. Ltd. Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Samsung Bioepis Co. Ltd. Sales and Growth Rate from 2014-2020

Figure Samsung Bioepis Co. Ltd. Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Intas Pharmaceuticals Ltd. Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Intas Pharmaceuticals Ltd. Sales and Growth Rate from 2014-2020

Figure Intas Pharmaceuticals Ltd. Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Pfizer, Inc. Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Pfizer, Inc. Sales and Growth Rate from 2014-2020

Figure Pfizer, Inc. Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Celltrion Inc. Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Celltrion Inc. Sales and Growth Rate from 2014-2020

Figure Celltrion Inc. Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Sandoz International GmbH Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Sandoz International GmbH Sales and Growth Rate from 2014-2020

Figure Sandoz International GmbH Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Teva Pharmaceutical Industries Ltd Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Teva Pharmaceutical Industries Ltd Sales and Growth Rate from 2014-2020

Figure Teva Pharmaceutical Industries Ltd Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Global Oncology Biosimilars Value ($) and Growth Rate Forecast by Regions (2021-2026)

Table Global Oncology Biosimilars Production and Growth Rate Forecast by Regions (2021-2026)

Table Global Oncology Biosimilars Consumption and Growth Rate Forecast by Regions (2021-2026)

Table Global Oncology Biosimilars Production and Growth Rate Forecast by Types (2021-2026)

Table Global Oncology Biosimilars Consumption and Growth Rate Forecast by End-User/Applications (2021-2026)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390